A Phase 1, Partially-Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose With a Food Effect Cohort and Multiple Ascending Dose and a Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, Pharmacokinetics and the Pharmacokinetic Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Adult Subjects.

Trial Profile

A Phase 1, Partially-Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose With a Food Effect Cohort and Multiple Ascending Dose and a Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, Pharmacokinetics and the Pharmacokinetic Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Adult Subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs TBA 7371 (Primary) ; Bupropion; Midazolam
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 28 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Aug 2017.
    • 29 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top